LIA
CRL icon

LS Investment Advisors’s Charles River Laboratories CRL Stock Holding History

LS Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,815
Closed -$816K – 287
2021
Q1 		$816K Sell
2,815
-530
-16% -$147K 0.05% 259
2020
Q4 		$836K Buy
3,345
+243
+8% +$57.9K 0.04% 298
2020
Q3 		$702K Sell
3,102
-108
-3% -$22.4K 0.04% 306
2020
Q2 		$560K Buy
3,210
+146
+5% +$23.3K 0.03% 342
2020
Q1 		$387K Hold
3,064
– – 0.03% 395
2019
Q4 		$468K Buy
3,064
+424
+16% +$58.7K 0.03% 504
2019
Q3 		$349K Buy
2,640
+53
+2% +$7.11K 0.02% 574
2019
Q2 		$367K Sell
2,587
-187
-7% -$25.4K 0.02% 558
2019
Q1 		$403K Sell
2,774
-104
-4% -$13.7K 0.03% 530
2018
Q4 		$326K Sell
2,878
-802
-22% -$100K 0.02% 573
2018
Q3 		$495K Sell
3,680
-256
-7% -$31.6K 0.03% 499
2018
Q2 		$442K Buy
3,936
+103
+3% +$11.1K 0.03% 549
2018
Q1 		$409K Sell
3,833
-295
-7% -$31.8K 0.02% 572
2017
Q4 		$452K Buy
4,128
+319
+8% +$34.7K 0.03% 549
2017
Q3 		$411K Sell
3,809
-162
-4% -$16.6K 0.02% 609
2017
Q2 		$402K Buy
3,971
+580
+17% +$53.4K 0.02% 602
2017
Q1 		$305K Sell
3,391
-36
-1% -$3.06K 0.02% 678
2016
Q4 		$261K Buy
3,427
+121
+4% +$9.19K 0.02% 694
2016
Q3 		$276K Buy
3,306
+169
+5% +$14.2K 0.02% 628
2016
Q2 		$259K Buy
3,137
+1,279
+69% +$105K 0.02% 655
2016
Q1 		$141K Buy
1,858
+138
+8% +$10.2K 0.01% 745
2015
Q4 		$138K Sell
1,720
-24
-1% -$1.73K 0.01% 741
2015
Q3 		$111K Sell
1,744
-51
-3% -$3.66K 0.01% 807
2015
Q2 		$126K Buy
+1,795
New +$133K 0.01% 797

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

LS Investment Advisors's CRL Position: Q2 2021 in Review

LS Investment Advisors sold out of Charles River Laboratories (CRL) in Q2 2021, closing a stake of 2,815 shares — an estimated $816K sold.

LS Investment Advisors first reported a position in CRL in Q2 2015 and held it in 24 quarters. The position peaked at $836K in Q4 2020. 639 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

  • LS Investment Advisors reported no remaining Charles River Laboratories position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 2,815 Charles River Laboratories shares in Q2 2021, an estimated $816K.
  • LS Investment Advisors first reported a position in Charles River Laboratories in Q2 2015 and held it in 24 quarters.
  • LS Investment Advisors's Charles River Laboratories position peaked at $836K in Q4 2020.
  • 639 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.